Filing Analysis
Forum Markets, Inc. issued a press release on April 29, 2026, providing an update on its existing share repurchase program. The disclosure was made under Item 7.01 (Regulation FD) and does not specify the dollar amount or share volume of the repurchases within the body of the 8-K.
Key Facts
- The company issued a press release on April 29, 2026, regarding its share repurchase program.
- The filing was submitted under Item 7.01 (Regulation FD) and Item 9.01 (Exhibits).
- The report was signed by McAndrew Rudisill, Chief Executive Officer.
- The company's common stock is listed on The Nasdaq Stock Market LLC under the symbol FRMM.
Forum Markets, Inc. filed a Certificate of Elimination to remove the Series B Convertible Preferred Stock designation from its Certificate of Incorporation. No shares of the Series B Preferred Stock were issued or outstanding at the time of the filing.
Key Facts
- The Certificate of Elimination was filed with the Secretary of State of Delaware on April 23, 2026.
- The elimination became effective at 12:01 a.m. on April 24, 2026.
- The Series B Convertible Preferred Stock was originally designated on September 20, 2024.
- The company confirmed that zero shares of the Series B Preferred Stock were issued or outstanding.
- The action effectively returns the shares that were designated as Series B to the status of authorized but unissued preferred stock.
Forum Markets announced the reinitiation of its share repurchase program and the formation of an independent Special Committee to explore strategic alternatives, including potential mergers, asset sales, or a return of capital to shareholders.
Red Flags
- The company is considering a return of 'substantially all' capital to shareholders, which often indicates the absence of a viable long-term business strategy.
- Frequent corporate identity changes: The company has transitioned from 180 Life Sciences Corp to ETHZilla Corp to Forum Markets Inc.
Key Facts
- Board authorized the reinitiation of a share repurchase program on April 15, 2026, which may exceed Rule 10b-18 safe harbor volume limitations.
- A Special Committee of independent directors (Angela Dalton, Michael Edwards, and Jason New) was formed to evaluate value-maximizing proposals.
- Clear Street LLC has been retained as an independent financial advisor to support the strategic review.
- Strategic options under consideration include mergers, asset sales, partnerships, or returning substantially all capital to shareholders if no suitable proposal is found.
- The company was formerly known as ETHZilla Corporation and 180 Life Sciences Corp.
Forum Markets Inc. (formerly ETHZilla and 180 Life Sciences) announced a strategic pivot into AI infrastructure financing, committing $25 million to $50 million for bridge loans to fund NVIDIA GPU acquisitions. The company has partnered with a third-party originator to facilitate these loans, targeting mid-teens annualized returns to support its tokenized product pipeline.
Red Flags
- Significant and rapid business model pivots from biotechnology (180 Life Sciences) to crypto (ETHZilla) to AI infrastructure lending.
- Multiple name changes within a short period, which is often associated with distressed micro-cap entities.
- Definitive agreements for the initial $25M-$50M transaction have not yet been executed.
- High reliance on a third-party partner for deal origination and loan management.
Key Facts
- Entered into a framework with a third-party AI infrastructure bridge credit originator to finance NVIDIA GPU acquisitions.
- Expected first transaction is a $25 million to $50 million loan to a U.S.-based neocloud operator.
- Targeting annualized returns in the mid-teens with repayment expected upon funding of term take-outs.
- The company underwent two name changes recently, from 180 Life Sciences Corp. to ETHZilla Corporation, and then to Forum Markets, Incorporated.
- The investment yield is intended to enhance the return profile of the company's tokenized product pipeline.
Forum Markets, Inc. (formerly 180 Life Sciences Corp) entered into a Second Amended and Restated Sales Agreement to transition its 'at-the-market' (ATM) offering program back to a previous registration statement. The company will cease sales under its WKSI Registration Statement and resume sales under its June Registration Statement (File No. 333-288194).
Red Flags
- Frequent corporate identity changes (three names mentioned: 180 Life Sciences, ETHZilla, and Forum Markets).
- Transitioning away from a WKSI (Well-Known Seasoned Issuer) registration statement often indicates a drop in market capitalization below the $700 million threshold required to maintain WKSI status.
- Ongoing reliance on 'at-the-market' offerings which typically result in continuous shareholder dilution.
Key Facts
- Agreement dated April 8, 2026, with Clear Street LLC and TCBI Securities, Inc. (Texas Capital Securities).
- The company is transitioning its ATM program from the WKSI Registration Statement (File No. 333-289811) back to the June Registration Statement (File No. 333-288194).
- The company has undergone multiple name changes: from 180 Life Sciences Corp. to ETHZilla Corporation, and now Forum Markets, Incorporated.
- No other material changes were made to the terms of the existing sales agreement.
Forum Markets, Inc. approved significant equity incentive awards for its CEO and CFO, totaling over $5.9 million in grant value. The awards are structured as a mix of time-vesting restricted stock units and performance-based units tied to stock price hurdles of $5.00, $7.50, and $10.00.
Red Flags
- The rescission of a prior equity grant (136,500 shares) in December 2025 followed by a multi-million dollar grant suggests significant compensation recalibration.
- High total grant value relative to typical micro-cap executive compensation (CEO total ~$5.18M).
Key Facts
- CEO McAndrew Rudisill granted a one-time initial award of $4,285,500 and a pro-rated 2025 award of $898,194.
- CFO John Saunders granted an equity award with a grant date value of $750,000.
- Awards consist of 60% Performance Stock Units (PSUs) and 40% Restricted Stock Units (RSUs).
- PSU vesting is contingent on achieving share price hurdles of $5.00, $7.50, and $10.00 within five years.
- Hurdles require the closing price to meet or exceed the target for at least 30 trading days within a consecutive 60-day period.
- A previous grant of 136,500 shares to the CEO from November 2025 was rescinded in December 2025 prior to these new grants.
Forum Markets, Inc. announced its financial results for the fiscal quarter and full year ended December 31, 2025. The filing includes a press release and an earnings presentation used during a conference call on March 31, 2026.
Key Facts
- Financial results cover the fiscal quarter and year ended December 31, 2025.
- The company held a conference call and webcast on March 31, 2026, to discuss the results.
- Exhibit 99.1 contains the press release and Exhibit 99.2 contains the earnings presentation.
- The company's common stock is traded on The Nasdaq Stock Market LLC under the symbol FRMM.
Forum Markets, Inc. entered into a $150 million revolving Master Loan Purchase Agreement with Zippy Loans, LLC to acquire manufactured home chattel loans over a five-year period. The company concurrently completed an initial purchase of 31 loans for approximately $1.44 million and disclosed a 15% ownership stake in the counterparty's parent company.
Red Flags
- Transaction involves a related party as the Company owns 15% of the counterparty's parent company.
- The $150 million aggregate commitment represents a substantial long-term obligation relative to the initial $1.44 million transaction.
Key Facts
- Entered into a $150,000,000 Master Loan Purchase Agreement (MLPA) and Master Loan Servicing Agreement (MLSA) with Zippy Loans, LLC on March 23, 2026.
- The agreement involves a five-year revolving commitment to purchase manufactured home chattel loan receivables.
- Initial purchase of 31 loans completed for $1,436,710.67, funded with cash on hand.
- The Company holds a 15% fully-diluted ownership interest in Zippy, Inc., the parent of the counterparty.
- A specific purchase commitment of $15,000,000 is established for the period ending June 30, 2026.
Forum Markets (FRMM) established a $10 million warehouse credit facility to finance auto loan receivables and disclosed the liquidation of 4,200 Ether (ETH) for approximately $8.15 million to fund operations. The company retains a significant crypto treasury of 61,650 ETH while pivoting toward AI-driven auto finance and asset tokenization.
Red Flags
- The company is actively selling core crypto assets to 'complete its business plans,' suggesting a reliance on asset liquidation for operational funding.
- Complexity risk arising from the combination of crypto holdings, AI credit analytics, and auto loan warehousing.
Key Facts
- Entered into a $10,000,000 Warehouse Facility Agreement (WFA) with Anchored Finance, LLC on March 3, 2026.
- The company's subsidiary, ETHZilla Auto Loans LLC, acts as the lender, providing interim financing for auto loan receivables.
- Sold 4,200 ETH since February 4, 2026, at an average price of $1,938.78 per ETH, generating $8,147,074 in proceeds.
- Maintains a remaining balance of 61,650 ETH on the balance sheet.
- The facility supports loans originated through Automatic USA, partnered with Karus, Inc. (in which Forum holds a 20% equity interest).
- The WFA has an initial 12-month term with automatic six-month renewals.
ETHZilla Corporation has changed its corporate name to Forum Markets, Incorporated and will update its Nasdaq ticker symbol from ETHZ to FRMM effective March 2, 2026. The company also launched a new corporate website as part of this rebranding effort.
Key Facts
- Name change from ETHZilla Corporation to Forum Markets, Incorporated became effective February 25, 2026.
- Ticker symbol will change from 'ETHZ' to 'FRMM' at the market open on March 2, 2026.
- The name change was approved by the Board of Directors without requiring a stockholder vote under Delaware law.
- A new corporate website was launched at www.forum-markets.com.
- There is no change to the CUSIP number for the company's common stock.